drugset / Trial / NCT00918177
An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate blood level profiles of multiple oral doses of AP09004 vs. active control and to determine its safety and efficacy in Parkinson's patients.
Timeline
- Start
- 2009-07
- Primary completion
- 2012-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AP09004 | Unknown | — | Oral |
| Subject | Carbidopa | Unknown | — | — |
| Subject | Levodopa | Small molecule | — | — |